Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.

被引：1
|
作者：
Akce, Mehmet
Alese, Olatunji B.
Shaib, Walid Labib
Wu, Christina Sing-Ying
Lesinski, Gregory B.
El-Rayes, Bassel F.
机构：
[1] Winship Canc Inst, Atlanta, GA USA
[2] Ohio State Univ, Arthur G James Canc Hosp, Columbus, OH USA
[3] Richard J Solove Res Inst, Columbus, OH USA
[4] Emory Univ Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.TPS526
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Endometrial Carcinoma
    Makker, Vicky
    Rasco, Drew
    Dutcus, Corina
    Stepan, Daniel
    Li, Di
    Schmidt, Emmett
    Shumaker, Robert
    Young, Louise
    Taylor, Matthew
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 152 - 153
  • [42] Population pharmacokinetics of ripretinib in patients with advanced malignancies.
    George, Suzanne
    Janku, Filip
    Chi, Ping
    von Mehren, Margaret
    Somaiah, Neeta
    Gelderblom, Hans
    Jones, Robin L.
    Allard, Martine
    Taylor, Adekemi
    Li, Xiaoyan
    Meade, Julie
    Reichert, Vienna
    Ruiz-Soto, Rodrigo
    Wang, Jing
    Heinrich, Michael C.
    CANCER RESEARCH, 2021, 81 (13)
  • [43] A phase II clinical trial of ipilimumab/nivolumab combination immunotherapy in patients with rare upper gastrointestinal, neuroendocrine, and gynecological malignancies.
    Klein, Oliver
    Kee, Damien
    Markman, Ben
    Lee, Rachael Chang
    Michael, Michael
    Mileshkin, Linda R.
    Scott, Clare L.
    Linklater, Richelle
    Menon, Sid
    Tebbutt, Niall C.
    Palmer, Jodie
    Behren, Andreas
    Cebon, Jonathan S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [44] Phase I expansion study of sunitinib and bevacizumab in patients with advanced solid malignancies.
    Mittal, Kriti
    Koon, Henry B.
    Elson, Paul
    Triozzi, Pierre L.
    Dowlati, Afshin
    Borden, Ernest C.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] A PHASE I STUDY TO ASSESS FOOD EFFECT ON OPROZOMIB IN PATIENTS WITH ADVANCED MALIGNANCIES.
    Harvey, R. D.
    Gore, L.
    Wang, D.
    Mita, A.
    Sharma, S.
    Nemunaitis, J.
    Papadopoulos, K.
    Pinchasik, D.
    Ou, Y.
    Demirhan, E.
    Cutler, R. E., Jr.
    Tsimberidou, A. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S98 - S99
  • [46] Phase I study of RFS 2000 and gemcitabine (Gem) in patients with advanced malignancies.
    Fracasso, PM
    Tan, BR
    Sun, SL
    Revell, SM
    Lenaz, L
    CLINICAL CANCER RESEARCH, 2000, 6 : 4515S - 4515S
  • [47] Brequinar in combination with cisplatin in patients with advanced malignancies. A phase I study with pharmacokinetics
    Burris, A
    Raymond, E
    Awada, A
    Kuhn, J
    O'Rourke, J
    Brentzel, J
    Lynch, W
    King, SY
    Brown, T
    Von Hoff, D
    ANNALS OF ONCOLOGY, 1998, 9 : 125 - 125
  • [48] Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial
    Voisin, Allison
    Terret, Catherine
    Schiffler, Camille
    Bidaux, Anne-Sophie
    Vanacker, Helene
    Perrin-Niquet, Marlene
    Barbery, Maud
    Vinceneux, Armelle
    Eberst, Lauriane
    Stephan, Pierre
    Garin, Gwenaele
    Spaggiari, Dany
    Perol, David
    Grinberg-Bleyer, Yenkel
    Cassier, Philippe A.
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2111 - 2120
  • [49] Phase 0 Clinical Trial of the Poly (ADP-Ribose) Polymerase Inhibitor ABT-888 in Patients With Advanced Malignancies
    Kummar, Shivaani
    Kinders, Robert
    Gutierrez, Martin E.
    Rubinstein, Larry
    Parchment, Ralph E.
    Phillips, Lawrence R.
    Ji, Jiuping
    Monks, Anne
    Low, Jennifer A.
    Chen, Alice
    Murgo, Anthony J.
    Collins, Jerry
    Steinberg, Seth M.
    Eliopoulos, Helen
    Giranda, Vincent L.
    Gordon, Gary
    Helman, Lee
    Wiltrout, Robert
    Tomaszewski, Joseph E.
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) : 2705 - 2711
  • [50] Phase I study of pasireotide in combination with FOLFIRI in gastrointestinal malignancies.
    Byer, Jennifer Elizabeth
    Mahipal, Amit
    Shibata, David
    Siegel, Erin M.
    Almhanna, Khaldoun
    Fulp, William J.
    Williams-Elson, Irene
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345